121 filings
Page 5 of 7
8-K
6ynp86jy 4lckrof5n8r
18 Mar 20
Nemaura To Prepare for Launch of sugarBEAT® CGM In the U.S. Following FDA Feedback
4:07pm
8-K
d4thtit6zch4shfo
10 Mar 20
Nemaura Medical enters into multiple verbal non-binding agreements for its sugarBEATÒplatform
4:31pm
8-K
56gwpx1zd
6 Mar 20
Entry into a Material Definitive Agreement
5:03pm
8-K
cymh0b677tblc3avagu
3 Mar 20
Nemaura Medical Launches sugarBEATÒApp on Play Store Ahead of its Planned Commercial Launch of BEATÒdiabetes Subscription Service
4:30pm
8-K
urxvj a9j
25 Feb 20
Regulation FD Disclosure
4:31pm
8-K
ocf4dgrx
23 Dec 19
Other Events
8:01am
8-K
dwudtaeydv2o8
4 Dec 19
Nemaura Medical Announces 1 for 10 Reverse Split Intended to Attract a Wider Universe of Institutional Investors
10:13am
8-K
eevkhm g3xqcvftx
15 Oct 19
Regulation FD Disclosure
4:05pm
8-K
sp4g059q1 vkj
9 Aug 19
Results of Operations and Financial Condition
1:32pm
8-K
le1sj
7 Aug 19
Other Events
8:32am
8-K
1s9gsqgsz4qu9
1 Aug 19
Nemaura Medical Inc. Announces $8 million Senior Debt Facility Provided by Existing Investors
8:42am
8-K
v6o7t6lr7nn0muo dals
17 Jul 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:39pm
8-K
eh6bdbib46htda eoxon
10 Jul 19
Other Events
8:27am
8-K
co5kp4tx63m89jrs
29 May 19
Other Events
8:33am
8-K
8xhhbi
23 Apr 19
Final step required prior to filing de novo application to the U.S. Food and Drug Administration
8:02am
8-K
m66tp9d7av4xw kzle0
19 Apr 19
Other Events
9:47am
8-K
izpa3obix3p
16 Apr 19
Enhances Product Capabilities in Advance of CE Mark Approval
11:41am
8-K
fl9m7b183 bu
27 Mar 19
Submission of Matters to a Vote of Security Holders
4:13pm
8-K
u3n99p 0gmzw3u3v09f
8 Feb 19
Departure of Directors or Certain Officers
4:25pm
8-K
c25 iciygq1d9h694
26 Dec 18
Entry into a Material Definitive Agreement
5:02pm